Paper12480697
SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.
Wang J and 9 others. Blood, 2003. Cited by 177 papers, by iCite.
Cite this record
ConductScience Library. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Papers, record 12480697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12480697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow | Major topic |
| Cord Blood Stem Cell Transplantation | Major topic |
| Hematopoietic Stem Cells | Major topic |
| Animals | |
| Antigens, CD34 | |
| Bone Marrow Transplantation | |
| Cell Lineage | |
| Cell Movement | |
| Cell Separation | |
| Clone Cells | |
| Colony-Forming Units Assay | |
| Graft Survival | |
| Humans | |
| Infant, Newborn | |
| Injections | |
| Lymphocytes | |
| Mice | |
| Mice, Inbred NOD | |
| Mice, SCID | |
| Myeloid Cells | |
| Receptors, CXCR4 | |
| Severe Combined Immunodeficiency | |
| Transplantation Chimera | |
| Transplantation, Heterologous |
Source PubMed
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 177 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42380918 | The ubiquitin E3 ligase TRIM59 in myeloid cell regulates complement C3 through degrading CCAAT/enhancer binding protein β to promote neuron survival after ischemic stroke. | Cell Biosci | 2026 | https://conductscience.org/library/papers/42380918 | PubMed |
| 40002599 | Distinct Phenotypic and Molecular Characteristics of CD34- and CD34+ Hematopoietic Stem/Progenitor Cell Subsets in Cord Blood and Bone Marrow Samples: Implications for Clinical Applications. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40002599 | PubMed |
| 38322982 | α1,3-fucosylation treatment improves cord blood CD34 negative hematopoietic stem cell navigation. | iScience | 2024 | https://conductscience.org/library/papers/38322982 | PubMed |
| 37511462 | Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511462 | PubMed |
| 35915364 | Adult Stem Cell Therapy as Regenerative Medicine for End-Stage Liver Disease. | Adv Exp Med Biol | 2022 | https://conductscience.org/library/papers/35915364 | PubMed |
| 35581599 | Direct bone marrow injection of human bone marrow-derived stromal cells into mouse femurs results in greater prostate cancer PC-3 cell proliferation, but not specifically proliferation within the injected femurs. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35581599 | PubMed |
| 35531956 | Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment. | JCI Insight | 2022 | https://conductscience.org/library/papers/35531956 | PubMed |
| 34910301 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). | Eur J Immunol | 2021 | https://conductscience.org/library/papers/34910301 | PubMed |
| 34869042 | Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research. | Front Oncol | 2021 | https://conductscience.org/library/papers/34869042 | PubMed |
| 33845908 | Human bone marrow-derived stromal cell behavior when injected directly into the bone marrow of NOD-scid-gamma mice pre-conditioned with sub-lethal irradiation. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/33845908 | PubMed |
| 33603749 | Advances in Human Immune System Mouse Models for Studying Human Hematopoiesis and Cancer Immunotherapy. | Front Immunol | 2020 | https://conductscience.org/library/papers/33603749 | PubMed |
| 32987729 | Characterization of Hematopoiesis in Sickle Cell Disease by Prospective Isolation of Stem and Progenitor Cells. | Cells | 2020 | https://conductscience.org/library/papers/32987729 | PubMed |
| 31697695 | Capacity of the medullary cavity of tibia and femur for intra-bone marrow transplantation in mice. | PLoS One | 2019 | https://conductscience.org/library/papers/31697695 | PubMed |
| 31633216 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). | Eur J Immunol | 2019 | https://conductscience.org/library/papers/31633216 | PubMed |
| 30982173 | One-Year Observation of the SCID-Repopulating Cell Activities of Human Cord Blood-Derived CD34-Positive and -Negative Hematopoietic Stem Cells. | Stem Cell Rev Rep | 2019 | https://conductscience.org/library/papers/30982173 | PubMed |
| 30972754 | Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery. | Br J Haematol | 2019 | https://conductscience.org/library/papers/30972754 | PubMed |
| 30046987 | The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units. | Int J Hematol | 2018 | https://conductscience.org/library/papers/30046987 | PubMed |
| 29875383 | A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells. | Nat Commun | 2018 | https://conductscience.org/library/papers/29875383 | PubMed |
| 29399087 | Simultaneous harvesting of endothelial progenitor cells and mesenchymal stem cells from the human umbilical cord. | Exp Ther Med | 2018 | https://conductscience.org/library/papers/29399087 | PubMed |
| 29296932 | Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44. | Blood Adv | 2017 | https://conductscience.org/library/papers/29296932 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| CXCL12 | 6387 | PubTator's text mining | https://conductscience.org/library/genes/6387 | NCBI Gene |
| CXCR4 | 7852 | PubTator's text mining | https://conductscience.org/library/genes/7852 | NCBI Gene |
| SRC | 6714 | PubTator's text mining | https://conductscience.org/library/genes/6714 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12480697
GET https://conductscience.org/api/papers/v1/12480697/cited_by?page=2